Results 111 to 120 of about 19,806 (216)

cfDNA As A Metabolic Marker

open access: yesMedicine & Science in Sports & Exercise, 2019
David Ochmann   +3 more
openaire   +2 more sources

Neutrophil Extracellular Traps in Atherosclerosis and Cardiovascular Disease

open access: yesMedComm, Volume 7, Issue 10, October 2026.
NETs as integrated effectors in the atherosclerotic cardiovascular disease continuum. Activated neutrophils release NETs that promote endothelial injury, thrombo‐inflammation, and plaque destabilization throughout atherosclerotic disease progression. Created with BioRender.com.
Ji Zhang   +9 more
wiley   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol

open access: yesBJU International, Volume 138, Issue 4, Page 607-619, October 2026.
Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan   +13 more
wiley   +1 more source

Soluble Immune Checkpoints and Anti‐HLA Antibodies in Kidney Transplant Recipients: Associations With Kidney Function

open access: yesImmunology, Volume 179, Issue 2, Page 269-286, October 2026.
Soluble immune checkpoints, anti‐HLA panel‐reactive antibodies, and kidney function parameters were evaluated to investigate their associations with early graft function. Pre‐transplant patients showed higher levels of sCD25, sPD‐L1, sTIM‐3, Gal‐9, sCD27, and sPD‐L2 than healthy controls, while post‐transplant temporal changes were observed in sCD25 ...
Cemil Pehlivanoğlu   +8 more
wiley   +1 more source

Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT The differentiation between benign and malignant biliary strictures remains a significant clinical challenge. Recent studies have suggested that next generation sequencing (NGS) can improve the diagnostic accuracy. However, evidence on its performance in routine clinical practice is limited. Therefore, validation of the diagnostic value of NGS
Antonia Gillmeister   +6 more
wiley   +1 more source

Apparentness of Unseen Rejection Episodes Post Lung rLTx Is Reliably Enabled by ddcfDNA Detection

open access: yesHLA, Volume 108, Issue 4, October 2026.
ABSTRACT ddcfDNA emerged as a biomarker for post‐transplantation management strategies. Lung retransplant recipients represent a particularly vulnerable patient population with an increased risk of allograft injury. The demand for understanding if ddcfDNA levels differ between primary lung transplant recipients and lung retransplant recipients becomes ...
Aleksandra Gazikalovic   +7 more
wiley   +1 more source

Analysis of urinary kidney-specific cell-free DNA in preeclampsia. [PDF]

open access: yesPLoS One
Heron VC   +7 more
europepmc   +1 more source

Circulating cell-free DNA as a biomarker in systemic lupus erythematosus: A narrative review. [PDF]

open access: yesJ Transl Autoimmun
Garai KA   +6 more
europepmc   +1 more source

Predictive Value of Perfusate Cell-free DNA During Hypothermic and Normothermic Machine Perfusion of Donor Kidneys. [PDF]

open access: yesTransplant Direct
Bousnina K   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy